Clinical Trial Update: A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

View source ↗

Summary

A planned observational study to assess how rivaroxaban is used and its safety in children under 2 with venous thromboembolism; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism, Children Under 2 Years | Status: NOT_YET_RECRUITING